Mirtazapine
Back to searchMolecule Structure
Scientific Name
Mirtazapine
Description of the Drug
Mirtazapine is a tetracyclic antidepressant used in the treatment of major depression and is used off-label as a drug for insomnia and to increase appetite.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00370
http://www.drugbank.ca/drugs/DB00370
Brand Name(s)
Mirtazapine, Remeron, Remeron soltab, Zispin
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Apotex Inc Etobicoke Site, Sun Pharmaceutical Industries Inc, Actavis Laboratories Fl Inc, Watson Laboratories Inc, Upsher Smith Laboratories Llc, Roxane Laboratories Inc, Actavis Elizabeth Llc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor alpha-2 | PROTEIN FAMILY | ANTAGONIST | CHEMBL2095158 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL35408 | ||
PharmGKB | PA450522 | ||
Human Metabolome Database | HMDB0014514 | ||
DrugBank | DB00370 | ||
PubChem: Thomson Pharma | 14848184 | ||
PubChem | 4205 | ||
Mcule | MCULE-1174883554 | ||
LINCS | LSM-1706 | ||
Nikkaji | J22.953I | ||
BindingDB | 50115644 | ||
EPA CompTox Dashboard | DTXSID0023325 | ||
DrugCentral | 1816 | ||
Brenda | 210369 | ||
ChemicalBook | CB7463387 | CB0463388 | |
Guide to Pharmacology | 7241 | ||
rxnorm | REMERON | MIRATAZ | MIRTAZAPINE |
PubChem: Drugs of the Future | 12013213 | ||
KEGG Ligand | C07570 | ||
ChEBI | 6950 |